Latest news very goodThe most recent newsprogressing with another phase if the Gobblet trial co- therapy with Roche can only be viewed as good news. Ideally Roche steps up & buys the whole company. It was always noted by management, Majority of acquisitions came on the results of long standing clinical relationships. They certainly have that with Roche. Not to mention the phase 3 fast track approval for the pancreatic cancer co therapy.